The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries
and regions of the world, and is undoubtedly the defining public-health crisis of our time …

Nano/Microfluidic technologies are emerging as powerful enabling tools for diagnosis and
monitoring of infectious diseases in both developed and developing countries. Miniaturized …

We demonstrate an integrated platform that merges a microfluidic chip with lensless imaging
to target CD4+ T-lymphocyte counts for HIV point-of-care testing at resource-limited settings …

HIV has become one of the most devastating pathogens in human history. Despite fast
progress in HIV-related basic research, antiretroviral therapy (ART) remains the most …

The ability to rapidly identify immune cell subsets such as CD4 cells, which became possible
around the same time as the onset of the HIV/AIDS pandemic, was one of the greatest …

Background CD4+ T-lymphocyte count (CD4 count) is a standard method used to monitor
HIV-infected patients during anti-retroviral therapy (ART). The World Health Organization …

Background CD4+ T-cell enumeration (CD4 count) is used as a criterion to initiate
antiretroviral therapy (ART) in HIV patients and to monitor treatment efficacy. However …

Background: In order to expand the treatment of human immunodeficiency virus‐1 (HIV)
infected patients in Africa, millions will require cost‐effective CD4 counts. Supporting …

The fast and timely detection of various infectious and other diseases is a critical step in
deciding therapeutic outcomes which in turn enhance patient health and survival rates. In …

Abstract Background: An independent African Regional External Quality Assessment
Scheme (AFREQAS) was implemented from Johannesburg. The aim was to establish a …